Videos

Peter Schmidt, PhD, breaks down a major shift in FDA thinking that's changing how sponsors plan their earliest trials.

Creating Value Through Early Phase Trial Design: How the FDA’s Single Phase 3 Pivot Impacts Early Phases

Success in emerging biopharma depends not only on speed, but also on making confident, data-informed decisions early in development while managing increasing molecular complexity.

How to Support Emerging Biopharma Programs Through Rapid Candidate Identification

Sr. VP and President, Bioproduction Group

Discover how a new mid-scale DynaDrive™ bioreactor platform and KojoX™ philosophy are redefining supply-chain security and manufacturing consistency across a growing global network.

Leveraging an Innovative Mid-Scale Manufacturing Solution to Meet Diverse Needs

Ajay Damani, President of Coating Place, discusses the impact of the current CDMO landscape on oral solid dose pharmaceuticals.

Evolving to Meet Today's Pharmaceutical Demand

The evolution of Pace® Life Sciences from an analytical services firm to a full-service CDMO supporting the drug development lifecycle.

Integrated Solutions for Complex Drug Development

Discover how Piramal Pharma Solutions is innovating in integrated CDMO services, leveraging their Science Collective of experts to streamline drug substance and drug product programs from early development through commercialization.

CDMO Innovations in Integrated Services

Emily Schirmer, Catalent, explains how to accelerate the path to first-in-human trials as biologics pipelines grow more complex and timelines tighten.

How Biologic Developers Use Optimized Platforms and Operations to Reach First-in-Human Trials

Christian Houborg discusses how FUJIFILM Biotechnologies is helping customers navigate evolving patient demand and supply chain uncertainty.

Sponsored Videos